TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16301268

Group type: EXPERIMENTAL
Intervention: Epidural stimulation test (EST)
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Epidural pressure waveform analysis (EPWA)
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Combination of EST and EPWA
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Epidural stimulation test (EST) with sensory response
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Epidural pressure waveform analysis (EPWA) by age group
Number of subjects: 218
Study: 11925136

Group type: EXPERIMENTAL
Intervention: Laparoscopic paracervical lymphadenectomy
Number of subjects: 95

Group type: COMPARATOR
Intervention: Modified radical hysterectomy without paracervical dissection
Number of subjects: 95
Study: 9830578

Group type: EXPERIMENTAL
Intervention: Banding ligation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sclerotherapy
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 40
Study: 7852210

Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (rHuEPO) for treating maternal pregnancy anemia; specific dosage and duration not mentioned.
Number of subjects: 0
Study: 2800975

Group type: EXPERIMENTAL
Intervention: Sevoflurane with nitrous oxide
Number of subjects: 2

Group type: COMPARATOR
Intervention: Enflurane with nitrous oxide
Number of subjects: 2
Study: 1006255

Group type: EXPERIMENTAL
Intervention: RU 43-715 (nonsteroid anti-inflammatory agent)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Collagen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Same volunteers (4 and 8 weeks later)
Number of subjects: 0
Study: 30593158

Group type: EXPERIMENTAL
Intervention: Routine care plus a therapeutic education program (TENS-TEP group)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Routine care (TENS group)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: TENS-TEP group
Number of subjects: 97

Group type: COMPARATOR
Intervention: TENS group
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 97
Study: 28242040

Group type: EXPERIMENTAL
Intervention: Sertraline treatment
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 25762461

Group type: EXPERIMENTAL
Intervention: Standard cilengitide (2000 mg 2×/wk; n = 88)
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Intensive cilengitide (2000 mg 5×/wk during wk 1‐6, thereafter 2×/wk; n = 88)
Number of subjects: 265

Group type: COMPARATOR
Intervention: Control arm (chemoradiotherapy alone; n = 89)
Number of subjects: 265
Study: 23650397

Group type: EXPERIMENTAL
Intervention: GSK650394 (small molecule inhibitor for SGK1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GSK650394
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GSK650394 combined with RU486 (GR antagonist)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cortisol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SGK1 mRNA
Number of subjects: 0
Study: 21135196

Group type: EXPERIMENTAL
Intervention: MBSR therapy plus traditional therapy
Number of subjects: 25

Group type: COMPARATOR
Intervention: Traditional therapy alone
Number of subjects: 25
Study: 18085737

Group type: EXPERIMENTAL
Intervention: HAQ-DI score calculated with aids/devices
Number of subjects: 0

Group type: COMPARATOR
Intervention: HAQ-DI score calculated without aids/devices
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HAQ-DI score with aids/devices
Number of subjects: 0

Group type: COMPARATOR
Intervention: HAQ-DI score without aids/devices
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Effect Size (ES) with aids/devices
Number of subjects: 0

Group type: COMPARATOR
Intervention: Effect Size (ES) without aids/devices
Number of subjects: 0
Study: 17011443

Group type: EXPERIMENTAL
Intervention: Whole-pelvis radiotherapy (WP RT) + neoadjuvant and concurrent hormonal therapy (N&CHT)
Number of subjects: 649

Group type: EXPERIMENTAL
Intervention: Mini-pelvis radiotherapy (MP RT) + neoadjuvant and concurrent hormonal therapy (N&CHT)
Number of subjects: 649

Group type: COMPARATOR
Intervention: Prostate-only radiotherapy (PO RT) + neoadjuvant and concurrent hormonal therapy (N&CHT)
Number of subjects: 649
Study: 14693171

Group type: EXPERIMENTAL
Intervention: Streptokinase
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Streptococcal infection
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control
Number of subjects: 103
Study: 11766085

Group type: EXPERIMENTAL
Intervention: Mechanical bowel cleansing plus oral antimicrobial prophylaxis with kanamycin and erythromycin for 2 days prior to surgery (group 2)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Mechanical bowel cleansing with polyethylene glycol alone (group 1)
Number of subjects: 143
Study: 9028540

Group type: EXPERIMENTAL
Intervention: Tibolone treatment
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 69
Study: 8273859

Group type: COMPARATOR
Intervention: Cefazolin 1 g intravenously every 8 hours for 48 hours (8 doses, n = 425)
Number of subjects: 702

Group type: EXPERIMENTAL
Intervention: Cefuroxime 1.5 g 1 hour prior to surgery plus 1.5 g every 12 hours for 3 additional doses (4 doses, n = 277)
Number of subjects: 702

Group type: COMPARATOR
Intervention: Cefazolin
Number of subjects: 702

Group type: EXPERIMENTAL
Intervention: Cefuroxime
Number of subjects: 702
Study: 3446308

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Phenelzine (high dose)
Number of subjects: 64
Study: 2706320

Group type: EXPERIMENTAL
Intervention: BY912 400 mg theophylline capsules
Number of subjects: 12

Group type: COMPARATOR
Intervention: Theo-24 capsules
Number of subjects: 12
Study: 31767473

Group type: EXPERIMENTAL
Intervention: IGRT-R (reduced CTV-PTV margins)
Number of subjects: 3216

Group type: EXPERIMENTAL
Intervention: IGRT-S (standard CTV-PTV margins)
Number of subjects: 3216

Group type: COMPARATOR
Intervention: No IGRT
Number of subjects: 3216
Study: 29920123

Group type: EXPERIMENTAL
Intervention: Beta-glucan and vitamin D supplementation
Number of subjects: 52

Group type: COMPARATOR
Intervention: Vitamin D and placebo
Number of subjects: 52

Group type: COMPARATOR
Intervention: Vitamin D alone
Number of subjects: 52
Study: 28441573

Group type: EXPERIMENTAL
Intervention: Pictorial warnings with symbolic imagery
Number of subjects: 2044

Group type: EXPERIMENTAL
Intervention: Pictorial warnings with graphic images of health effects
Number of subjects: 2044

Group type: EXPERIMENTAL
Intervention: Pictorial warnings with personalized graphic images plus a personal testimonial
Number of subjects: 2044

Group type: COMPARATOR
Intervention: Text-only warnings
Number of subjects: 2044

Group type: EXPERIMENTAL
Intervention: Pictorial warnings (general)
Number of subjects: 2044
Study: 26524818

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided IUI (USG)
Number of subjects: 130
Study: 23228670

Group type: COMPARATOR
Intervention: Morphine 0.1mg (Group A)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Fentanyl 10 μg (Group B)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Fentanyl 10 μg + bilateral TAP block (Group C)
Number of subjects: 90
Study: 21310284

Group type: EXPERIMENTAL
Intervention: Chlormadinone acetate (CMA, 10 mg/day)
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Cyproterone acetate (CPA, 50 mg/day)
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Both CMA and CPA
Number of subjects: 187
Study: 19797305

Group type: EXPERIMENTAL
Intervention: Spinal manipulative therapy (SMT)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Stationary bicycle
Number of subjects: 36

Group type: COMPARATOR
Intervention: Low back extension exercises
Number of subjects: 36
Study: 16949079

Group type: EXPERIMENTAL
Intervention: Assessment of pressure ulcer diagnosis and grading using a 4-grade scale based on 50 images from foot/heel and 50 images from buttock/hip regions.
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Assessment of pressure ulcer diagnosis in the buttock/hip region.
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Assessment of pressure ulcer grading in the buttock/hip region.
Number of subjects: 7

Group type: COMPARATOR
Intervention: Comparison of agreement levels between nurses and physicians.
Number of subjects: 7
Study: 12869082

Group type: EXPERIMENTAL
Intervention: Celecoxib 200 mg twice daily
Number of subjects: 287

Group type: COMPARATOR
Intervention: Diclofenac 75 mg twice daily plus 20 mg of omeprazole daily
Number of subjects: 287
Study: 10597744

Group type: EXPERIMENTAL
Intervention: Sequential intensification program (SEQ‐INT)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Conventional chemotherapy regimen (CMF)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Rotational crossing program (ROT‐CROSS)
Number of subjects: 162
Study: 8983396

Group type: EXPERIMENTAL
Intervention: Pro‐SorbTM liquid
Number of subjects: 8

Group type: COMPARATOR
Intervention: Clinoril tablets
Number of subjects: 8
Study: 1756943

Group type: EXPERIMENTAL
Intervention: Endoscopic band ligation
Number of subjects: 0
Study: 7044412

Group type: EXPERIMENTAL
Intervention: 5% tolmetin
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 0.5% prednisolone
Number of subjects: 100

Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 100
Study: 31951030

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Unfractioned heparin (UFH)
Number of subjects: 102
Study: 30863028

Group type: EXPERIMENTAL
Intervention: CAU + NFT (20 sessions of 30 minutes each, 2‐3 sessions per week)
Number of subjects: 119

Group type: COMPARATOR
Intervention: CAU + exergame‐based training
Number of subjects: 119

Group type: COMPARATOR
Intervention: CAU (no active treatment)
Number of subjects: 119
Study: 28400200

Group type: EXPERIMENTAL
Intervention: Unilateral and bilateral constant-current DBS of the ventralis intermedius (VIM) nucleus of the thalamus
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Second contralateral VIM-DBS
Number of subjects: 127
Study: 26143052

Group type: EXPERIMENTAL
Intervention: Active neurodynamic mobilization program
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 48
Study: 23593932

Group type: EXPERIMENTAL
Intervention: Propranolol (80 mg per day maximum)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 21219094

Group type: EXPERIMENTAL
Intervention: TBI simulation (n=59)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control group (n=40)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Severe TBI (n=38)
Number of subjects: 99
Study: 19798507

Group type: EXPERIMENTAL
Intervention: PPH
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: THD
Number of subjects: 41
Study: 16508555

Group type: EXPERIMENTAL
Intervention: Pain intensity numerical rating scale (PI‐NRS)
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: Quebec Back Pain Disability Scale (QBPDS)
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: Euroqol (EQ)
Number of subjects: 442
Study: 14987306

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate aqueous nasal spray (FPANS) 200 microg once daily
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate aqueous nasal spray (FPANS) 200 microg once daily plus cetirizine (CTZ) 10 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate aqueous nasal spray (FPANS) 200 microg once daily plus montelukast (MSK) 10 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Cetirizine (CTZ) 10 mg plus montelukast (MSK) 10 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: All treatments (FPANS, FPANS plus CTZ, FPANS plus MSK, CTZ plus MSK)
Number of subjects: 100
Study: 15101888

Group type: EXPERIMENTAL
Intervention: Fentanyl 25-microg/h patch with local heat
Number of subjects: 6

Group type: COMPARATOR
Intervention: Fentanyl 25-microg/h patch without local heat
Number of subjects: 6
Study: 8697308

Group type: EXPERIMENTAL
Intervention: 1.25 mg ramipril
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 1449332

Group type: EXPERIMENTAL
Intervention: Automatic AV delay (linear reduction from 156 ms to 84 ms)
Number of subjects: 10
Study: 6141724

Group type: EXPERIMENTAL
Intervention: Prazosin and polythiazide
Number of subjects: 20

Group type: COMPARATOR
Intervention: Nadolol and polythiazide
Number of subjects: 20
Study: 30888908

Group type: EXPERIMENTAL
Intervention: Systemic therapy
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Combined locoregional and systemic therapy
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Locoregional therapy alone
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Performance status (PS) ≥2
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Older age, extrapericardial disease, and NPE at progression
Number of subjects: 29
Study: 29877727

Group type: EXPERIMENTAL
Intervention: Treatment for pediatric anxiety disorders
Number of subjects: 488
Study: 28594776

Group type: EXPERIMENTAL
Intervention: Retropubic sling
Number of subjects: 597

Group type: EXPERIMENTAL
Intervention: Transobturator sling
Number of subjects: 597

Group type: COMPARATOR
Intervention: Both sling types
Number of subjects: 597
Study: 26530743

Group type: EXPERIMENTAL
Intervention: 34 Gy in 1 fraction (arm 1)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: 48 Gy in 4 consecutive daily fractions (arm 2)
Number of subjects: 94
Study: 24084072

Group type: EXPERIMENTAL
Intervention: Tiotropium
Number of subjects: 168

Group type: COMPARATOR
Intervention: Salmeterol
Number of subjects: 168
Study: 21961181

Group type: EXPERIMENTAL
Intervention: Thalidomide induction therapy
Number of subjects: 85

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 85
Study: 19005931

Group type: EXPERIMENTAL
Intervention: Self-efficacy
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Flexibility
Number of subjects: 190
Study: 17345835

Group type: EXPERIMENTAL
Intervention: Nitrofurantoin
Number of subjects: 105

Group type: COMPARATOR
Intervention: Cotrimoxazole
Number of subjects: 105
Study: 14558437

Group type: EXPERIMENTAL
Intervention: Theophyllin 400 retard Heumann (formulation A) - 400 mg once daily
Number of subjects: 24

Group type: COMPARATOR
Intervention: Oral solution (formulation B) - 133 mg t.i.d.
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Theophylline sustained release formulation C - 375 mg once daily
Number of subjects: 24
Study: 10895372

Group type: EXPERIMENTAL
Intervention: Micronutrient antioxidants (selenium, beta-carotene, vitamin C, vitamin E, and methionine) with allopurinol
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 9487832

Group type: EXPERIMENTAL
Intervention: Braun Oral‐B Interclean‐ID2 with Flexi‐Tip gingival massage attachment
Number of subjects: 59

Group type: COMPARATOR
Intervention: Manual floss
Number of subjects: 59
Study: 7691604

Group type: EXPERIMENTAL
Intervention: Crystalloids
Number of subjects: 29

Group type: COMPARATOR
Intervention: Crystalloids and dextran 70
Number of subjects: 29
Study: 3544597

Group type: EXPERIMENTAL
Intervention: Antibiotic prophylaxis
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control (no antibiotic prophylaxis)
Number of subjects: 34
Study: 31902935

Group type: EXPERIMENTAL
Intervention: Educational Program for Promoting Appropriate Self-medication via Pharmacies and Pharmacists
Number of subjects: 62

Group type: COMPARATOR
Intervention: Medication/health class (control group)
Number of subjects: 62
Study: 30409202

Group type: EXPERIMENTAL
Intervention: 10-week, task-specific training program on an exergame-based balance training system (Physiomat®), 2 times per week
Number of subjects: 56
Study: 27748249

Group type: EXPERIMENTAL
Intervention: Sleep group (participants who slept after film viewing)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Wake group (participants who remained awake after film viewing)
Number of subjects: 65
Study: 25262434

Group type: EXPERIMENTAL
Intervention: Rosuvastatin (5 mg/day)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Atorvastatin (10 mg/day)
Number of subjects: 75
Study: 22661587

Group type: EXPERIMENTAL
Intervention: Sunitinib
Number of subjects: 361

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 361

Group type: COMPARATOR
Intervention: Placebo (RPSFT analysis)
Number of subjects: 361
Study: 20578283

Group type: EXPERIMENTAL
Intervention: Bimatoprost 0.03% preserved with 0.005% BAK
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Latanoprost 0.005% preserved with 0.02% BAK
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Travoprost 0.004% preserved with sofZia
Number of subjects: 106
Study: 19025535

Group type: EXPERIMENTAL
Intervention: Caudal midazolam (50 microg/kg) combined with 0.2% ropivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ropivacaine alone (without midazolam)
Number of subjects: 60
Study: 15908647

Group type: EXPERIMENTAL
Intervention: Doxorubicin-cyclophosphamide (AC) neoadjuvant chemotherapy (n = 24)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Doxorubicin-docetaxel (AD) neoadjuvant chemotherapy (n = 24)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Comparison of pretreatment biopsy and tumor excised after chemotherapy
Number of subjects: 48
Study: 12935395

Group type: EXPERIMENTAL
Intervention: Leflunomide at 20 mg once daily
Number of subjects: 566

Group type: COMPARATOR
Intervention: Methotrexate (MTX) at 15 mg once weekly
Number of subjects: 566

Group type: EXPERIMENTAL
Intervention: Leflunomide
Number of subjects: 566
Study: 11214769

Group type: EXPERIMENTAL
Intervention: Carvedilol 12.5 mg/day for 2 days and then 25 mg/day for 5 days
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 22
Study: 8090376

Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Beta-carotene supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2680994

Group type: EXPERIMENTAL
Intervention: 75 mg mesterolone daily
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: 150 mg mesterolone daily
Number of subjects: 157

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 157
Study: 781228

Group type: EXPERIMENTAL
Intervention: Fenoprofen (200 to 800 mg every six hours, median daily dose 1.8 gm)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 28470086

Group type: EXPERIMENTAL
Intervention: Parent Management Training - Oregon Model (PMTO)
Number of subjects: 353

Group type: EXPERIMENTAL
Intervention: Brief Parent Training (BPT)
Number of subjects: 353

Group type: COMPARATOR
Intervention: Both PMTO and BPT
Number of subjects: 353
Study: 28010884

Group type: EXPERIMENTAL
Intervention: Lumbar cistern drainage combined with intrathecal injection of antibiotics (LCD-ITI)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 60
Study: 26258455

Group type: EXPERIMENTAL
Intervention: Nintendo Wii (NW)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional Physical Therapy (CPT)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both NW and CPT
Number of subjects: 30
Study: 23665469

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA) 150mg daily
Number of subjects: 126

Group type: COMPARATOR
Intervention: Acetylsalicylic acid (ASA) 75mg daily
Number of subjects: 126
Study: 20224326

Group type: EXPERIMENTAL
Intervention: Meta-analysis of high-quality randomized-controlled trials
Number of subjects: 0
Study: 19057373

Group type: EXPERIMENTAL
Intervention: Caffeine citrate 5 mg/kg/d
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Caffeine citrate 20 mg/kg/d
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Caffeine citrate (both dosages)
Number of subjects: 110
Study: 16619180

Group type: EXPERIMENTAL
Intervention: Oral poliovirus vaccine (OPV)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Inactivated poliovirus vaccine (IPV)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Unimmunized infants
Number of subjects: 140
Study: 14668503

Group type: EXPERIMENTAL
Intervention: Point Contact Fixator (PC‐Fix)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Limited Contact Dynamic Compression Plate (LC‐DCP)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 92
Study: 10921433

Group type: EXPERIMENTAL
Intervention: Compliance with the smokeless tobacco policy during competition
Number of subjects: 5000

Group type: EXPERIMENTAL
Intervention: Compliance with the smokeless tobacco policy during practices
Number of subjects: 5000

Group type: EXPERIMENTAL
Intervention: Perception of policy contributing to decline in overall tobacco consumption
Number of subjects: 5000
Study: 9431897

Group type: EXPERIMENTAL
Intervention: Liquid meal (220 kJ)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Semisolid meal (1472 kJ)
Number of subjects: 30
Study: 1494127

Group type: EXPERIMENTAL
Intervention: Real occlusal adjustment
Number of subjects: 51

Group type: COMPARATOR
Intervention: Mock occlusal adjustment
Number of subjects: 51
Study: 3800700

Group type: EXPERIMENTAL
Intervention: 0.3 M sodium hydroxide
Number of subjects: 40

Group type: COMPARATOR
Intervention: Reverse ultrafiltration
Number of subjects: 40

Group type: COMPARATOR
Intervention: 3% hydrogen peroxide
Number of subjects: 40

Group type: COMPARATOR
Intervention: Water flush
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: NaOH
Number of subjects: 40

Group type: COMPARATOR
Intervention: Other methods (reverse ultrafiltration, 3% hydrogen peroxide, water flush)
Number of subjects: 40
Study: 31150120

Group type: EXPERIMENTAL
Intervention: Nimotuzumab plus cisplatin chemoradiotherapy (NCRT)
Number of subjects: 536

Group type: COMPARATOR
Intervention: Cisplatin chemoradiotherapy alone (CRT)
Number of subjects: 536
Study: 27596682

Group type: EXPERIMENTAL
Intervention: Submerged implants (n=30)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Non-submerged with esthetic healing abutment (n=30)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Non-submerged with anatomical healing abutment (n=30)
Number of subjects: 90
Study: 25877514

Group type: EXPERIMENTAL
Intervention: Social‐cognitive theory‐guided oral hygiene intervention (three face‐to‐face educational hands‐on sessions facilitated by a dentist)
Number of subjects: 197

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 197
Study: 24643752

Group type: EXPERIMENTAL
Intervention: New back school program (muscular physiological characteristics)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (healthy individuals)
Number of subjects: 56